#description: MAxO therapeutic annotations for rare diseases
#date: 2023-07-13
#tracker: https://github.com/monarch-initiative/MAxO/issues
disease_id	disease_name	citation	maxo_id	maxo_label	hpo_id	maxo_relation	evidence_code	extension_id	extension_label	attribute	creator	last_update	created_on
MONDO:0008854	Bardet-biedl Syndrome 1	PMID:20301537	MAXO:0000088	dietary intervention	HP:0000819	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-01-06
MONDO:0008854	Bardet-biedl Syndrome 1	PMID:20301537	MAXO:0000011	physical therapy	HP:0002141	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-01-06
MONDO:0008854	Bardet-biedl Syndrome 1	PMID:20301537	MAXO:0000930	speech therapy	HP:0000750	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-01-06
MONDO:0008854	Bardet-biedl Syndrome 1	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-01-06
MONDO:0021056	Adenomatous Polyposis Coli	https://www.ncbi.nlm.nih.gov/books/NBK1345/	MAXO:0001110	tumorectomy	HP:0100245	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-04-06	2022-01-25
MONDO:0021056	Adenomatous Polyposis Coli	https://www.ncbi.nlm.nih.gov/books/NBK1345/	MAXO:0000885	surgical removal procedure	HP:0030731	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-04-06	2022-01-26
MONDO:0021056	Adenomatous Polyposis Coli	https://www.ncbi.nlm.nih.gov/books/NBK1345/	MAXO:0000885	surgical removal procedure	HP:0004394	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-01-26
MONDO:0021056	Adenomatous Polyposis Coli	https://www.ncbi.nlm.nih.gov/books/NBK1345/	MAXO:0000885	surgical removal procedure	HP:0006722	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-01-26
MONDO:0009367	Mckusick-kaufman Syndrome	PMID:20301675	MAXO:0000004	surgical procedure	HP:0030010	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-01-31	2022-02-10
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000011	physical therapy	HP:0002355	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2022-02-14	2022-02-14
MONDO:0014432	Bardet-biedl Syndrome 2	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-02-15
MONDO:0014432	Bardet-biedl Syndrome 2	PMID:20301537	MAXO:0000088	dietary intervention	HP:0000819	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-02-15
MONDO:0010832	Bardet-biedl Syndrome 3	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-02-15
MONDO:0014433	Bardet-biedl Syndrome 4	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-15
MONDO:0011523	Bardet-biedl Syndrome 6	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-02-15
MONDO:0014435	Bardet-biedl Syndrome 7	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-02-15
MONDO:0014436	Bardet-biedl Syndrome 8	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-02-15
MONDO:0014437	Bardet-biedl Syndrome 9	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-15
MONDO:0014437	Bardet-biedl Syndrome 9	PMID:20301537	MAXO:0000930	speech therapy	HP:0000750	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-15
MONDO:0014438	Bardet-biedl Syndrome 10	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-02-15
MONDO:0014439	Bardet-biedl Syndrome 11	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-15
MONDO:0014440	Bardet-biedl Syndrome 12	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-15
MONDO:0014441	Bardet-biedl Syndrome 13	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-15
MONDO:0044308	Bardet-biedl Syndrome 21	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-17
MONDO:0044308	Bardet-biedl Syndrome 21	PMID:20301537	MAXO:0000930	speech therapy	HP:0000750	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-17
MONDO:0014442	Bardet-biedl Syndrome 14	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-17
MONDO:0010533	Arts Syndrome	PMID:8498830	MAXO:0000011	physical therapy	HP:0001251	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-07-12	2022-02-22
MONDO:0014444	Bardet-biedl Syndrome 16	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-02-25
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000011	physical therapy	HP:0007340	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2022-02-28	2022-02-28
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000011	physical therapy	HP:0002061	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2022-02-28	2022-02-28
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000011	physical therapy	HP:0006986	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-02-28
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000930	speech therapy	HP:0001260	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-02-28
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000324	skeletal muscle relaxant agent therapy	HP:0002061	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-02-28
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000324	skeletal muscle relaxant agent therapy	HP:0006986	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-02-28
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0000189	dyslipidemic agent therapy	HP:0005177	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-02-28
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0000572	hypoglycemic agent therapy	HP:0000819	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-02-28
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0000287	estrogen modifying agent therapy	HP:0000939	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-02-28
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0000283	hormone modifying therapy	HP:0000939	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-02-28
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0000110	vitamin D supplementation	HP:0000939	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-02-28
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0001139	calcium supplementation	HP:0000939	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-02-28
MONDO:0021056	Adenomatous Polyposis Coli	OMIM:175100	MAXO:0000221	nonsteroidal anti-inflammatory agent therapy	HP:0005227	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-03-01
MONDO:0021056	Adenomatous Polyposis Coli	OMIM:175100	MAXO:0001042	colectomy	HP:0005227	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-03-01
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0000930	speech therapy	HP:0001263	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-03-17
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0000011	physical therapy	HP:0001263	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-03-17
MONDO:0007039	Neurofibromatosis, Type Ii	PMID:20301380	MAXO:0000448	surgical resection	HP:0009592	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-03-17
MONDO:0007039	Neurofibromatosis, Type Ii	PMID:20301380	MAXO:0000448	surgical resection	HP:0009590	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-03-17
MONDO:0007039	Neurofibromatosis, Type Ii	PMID:20301380	MAXO:0000448	surgical resection	HP:0002888	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-03-17
MONDO:0007039	Neurofibromatosis, Type Ii	PMID:20301380	MAXO:0000448	surgical resection	HP:0009593	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-03-17
MONDO:0007039	Neurofibromatosis, Type Ii	PMID:20301380	MAXO:0000448	surgical resection	HP:0009589	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-03-17
MONDO:0007042	Saethre-chotzen Syndrome	PMID:20301368	MAXO:0000004	surgical procedure	HP:0000175	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-03-17
MONDO:0016862	Alagille Syndrome 1	PMID:20301450	MAXO:0001135	fat soluble vitamin supplementation	HP:0001508	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-10	2022-05-06
MONDO:0016862	Alagille Syndrome 1	PMID:20301450	MAXO:0001175	liver transplantation	HP:0001399	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-10	2022-05-06
MONDO:0007688	Myhre Syndrome	PMID:28406602	MAXO:0000011	physical therapy	HP:0001376	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-16	2022-05-06
MONDO:0007688	Myhre Syndrome	PMID:28406602	MAXO:0000011	physical therapy	HP:0001387	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-16	2022-05-06
MONDO:0007688	Myhre Syndrome	PMID:28406602	MAXO:0000066	supplemental oxygen therapy	HP:0002093	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-16	2022-05-06
MONDO:0007688	Myhre Syndrome	PMID:28406602	MAXO:0000504	tracheostomy	HP:0004894	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-16	2022-05-06
MONDO:0007510	Clouston Syndrome	PMID:20301379	MAXO:0000159	analgesic therapy	HP:0000972	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-05-16	2022-04-27
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0009030	hearing aid usage	HP:0000365	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-06
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0009025	cochlear device implantation	HP:0000365	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-06
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0009031	auditory rehabilitation	HP:0000365	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-06
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0009029	hearing therapy	HP:0000365	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-06
MONDO:0013252	Warsaw Breakage Syndrome	PMID:31169992	MAXO:0000930	speech therapy	HP:0000365	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-06
MONDO:0010200	Wilson Disease	PMID:20301685	MAXO:0001224	copper chelator agent therapy	HP:0010838	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-06
MONDO:0010200	Wilson Disease	PMID:20301685	MAXO:0001224	copper chelator agent therapy	MONDO:0010200	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-06
MONDO:0010200	Wilson Disease	PMID:20301685	MAXO:0000112	food antioxidant supplementation	MONDO:0010200	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-06
MONDO:0010196	Werner Syndrome	PMID:20301687	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0000518	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-06
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0009015	botulinum toxin therapy	HP:0000012	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-06
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0009015	botulinum toxin therapy	HP:0002061	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-06
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0009015	botulinum toxin therapy	HP:0006986	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-06
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0001055	gonadectomy	HP:0000149	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0001055	gonadectomy	HP:0000149	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-16	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0001967	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0003774	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0001967	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000652	ACE inhibitor therapy	HP:0003774	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0003774	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0001967	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0003774	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0001967	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000190	RAAS inhibitor therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0001967	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0009733	Nephrotic Syndrome, Type 4	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0001967	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0008682	Denys-drash Syndrome	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0003774	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0000097	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0007635	Frasier Syndrome	PMID:32352694	MAXO:0000653	angiotensin receptor blocker therapy	HP:0000100	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-06-07
MONDO:0012589	Pitt-hopkins Syndrome	PMID:22934316	MAXO:0000167	anticonvulsant agent therapy	HP:0001250	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-12	2022-06-10
MONDO:0012439	Alagille Syndrome 2	PMID:20301450	MAXO:0001124	anticholesteric agent therapy	HP:0001396	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-10
MONDO:0007064	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative,b Cell-negative, Nk Cell-negative, Due To Adenosine Deaminase Deficiency	PMID:20301656	MAXO:0000061	antibacterial agent therapy	HP:0002718	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-10
MONDO:0007064	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative,b Cell-negative, Nk Cell-negative, Due To Adenosine Deaminase Deficiency	PMID:20301656	MAXO:0000168	antiviral agent therapy	HP:0004429	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-10
MONDO:0007064	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative,b Cell-negative, Nk Cell-negative, Due To Adenosine Deaminase Deficiency	PMID:20301656	MAXO:0000174	anti-fungal agent therapy	HP:0002841	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-10
MONDO:0018919	Mccune-albright Syndrome	PMID:25719192	MAXO:0000294	antithyroid agent therapy	HP:0000836	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-12-03	2022-06-10
MONDO:0018919	Mccune-albright Syndrome	PMID:25719192	MAXO:0000234	aromatase inhibitor agent therapy	HP:0000826	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-12-03	2022-06-10
MONDO:0018919	Mccune-albright Syndrome	PMID:25719192	MAXO:0000283	hormone modifying therapy	HP:0000845	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-12-03	2022-06-10
MONDO:0018919	Mccune-albright Syndrome	PMID:25719192	MAXO:0001030	adrenalectomy	HP:0003118	TREATS	TAS				ORCID:0000-0001-5208-3432	2022-12-03	2022-06-10
MONDO:0008670	Waardenburg Syndrome, Type 1	PMID:20301703	MAXO:0009025	cochlear device implantation	HP:0008527	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-11
MONDO:0008221	Prolidase Deficiency	PMID:26110198	MAXO:0000061	antibacterial agent therapy	HP:0200042	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-06-14	2022-06-11
MONDO:0008953	Zellweger Syndrome	PMID:20301621	MAXO:0009030	hearing aid usage	HP:0000407	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-13
MONDO:0009959	Refsum Disease, Infantile Form	PMID:20301621	MAXO:0009030	hearing aid usage	HP:0000407	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-07	2022-06-13
MONDO:0008736	Peroxisome Biogenesis Disorder 2b	PMID:20301621	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0010696	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-07	2022-06-13
MONDO:0008953	Zellweger Syndrome	PMID:20301621	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0000518	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-06-13
MONDO:0008736	Peroxisome Biogenesis Disorder 2b	PMID:20301621	MAXO:0001117	seizure prevention recommendation	HP:0001250	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2023-02-07	2022-06-13
MONDO:0008953	Zellweger Syndrome	PMID:20301621	MAXO:0001117	seizure prevention recommendation	HP:0001250	PREVENTS	TAS				ORCID:0000-0002-4142-7153	2023-02-07	2022-06-13
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000160	antidepressant agent therapy	HP:0000712	TREATS	TAS				ORCID:0000-0002-4142-7153	2022-06-28	2022-02-28
MONDO:0010533	Arts Syndrome	PMID:8498830	MAXO:0000946	neurosurgical procedure	HP:0001057	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0013895	Adams-oliver Syndrome 3	PMID:27077170	MAXO:0000946	neurosurgical procedure	HP:0001057	TREATS	TAS			comment: "reconstruction by a neurosurgeon"	ORCID:0000-0001-5208-3432	2023-02-12	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000448	surgical resection	HP:0011781	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000448	surgical resection	HP:0002897	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000448	surgical resection	HP:0002865	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000429	external beam radiation therapy	HP:0002897	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000429	external beam radiation therapy	HP:0002865	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000448	surgical resection	HP:0000843	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008234	Multiple Endocrine Neoplasia, Type Iia	PMID:20301434	MAXO:0000294	antithyroid agent therapy	HP:0011781	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0008082	Multiple Endocrine Neoplasia, Type Iib	PMID:20301434	MAXO:0000448	surgical resection	HP:0011781	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0008082	Multiple Endocrine Neoplasia, Type Iib	PMID:20301434	MAXO:0000429	external beam radiation therapy	HP:0002865	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0012098	Spinocerebellar Ataxia 20	PMID:20301644	MAXO:0000930	speech therapy	HP:0001260	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0012098	Spinocerebellar Ataxia 20	PMID:20301644	MAXO:0000930	speech therapy	HP:0001618	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0012098	Spinocerebellar Ataxia 20	PMID:20301644	MAXO:0000011	physical therapy	HP:0002066	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-06-30
MONDO:0100252	Tumoral Calcinosis, Hyperphosphatemic, Familial	PMID:29389098	MAXO:0010113	dietary phosphate intake avoidance	HP:0002905	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0100252	Tumoral Calcinosis, Hyperphosphatemic, Familial	PMID:29389098	MAXO:0000448	surgical resection	HP:0003761	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0100252	Tumoral Calcinosis, Hyperphosphatemic, Familial	PMID:29389098	MAXO:0010113	dietary phosphate intake avoidance	HP:0003761	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0100252	Tumoral Calcinosis, Hyperphosphatemic, Familial	PMID:29389098	MAXO:0000277	phosphate binders agent therapy	HP:0003761	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0100252	Tumoral Calcinosis, Hyperphosphatemic, Familial	PMID:29389098	MAXO:0000221	NSAID therapy	HP:0100774	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-06-30
MONDO:0007947	Marfan Syndrome	PMID:20301510	MAXO:0000653	angiotensin-receptor blocker therapy	HP:0002616	PREVENTS	TAS				ORCID:0000-0002-0736-9199	2022-07-05	2022-02-10
MONDO:0007947	Marfan Syndrome	PMID:25405392	MAXO:0000187	beta-adrenergic antagonist agent therapy	HP:0002616	PREVENTS	PCS				ORCID:0000-0002-0736-9199	2022-07-05	2021-12-09
MONDO:0007534	Beckwith-wiedemann Syndrome	PMID:20301568	MAXO:0000500	airway management	HP:0000158	TREATS	TAS				ORCID:0000-0001-7941-2961	2022-07-05	2022-01-26
MONDO:0011182	Trimethylaminuria	PMID:20301282	MAXO:0010103	dietary trimethylamine intake avoidance	HP:0003614	PREVENTS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-07-06
MONDO:0011182	Trimethylaminuria	PMID:20301282	MAXO:0010105	dietary trimethylamine N-oxide intake avoidance	HP:0003614	PREVENTS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-07-06
MONDO:0011182	Trimethylaminuria	PMID:20301282	MAXO:0010104	dietary choline intake avoidance	HP:0003614	PREVENTS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-07-06
MONDO:0011182	Trimethylaminuria	PMID:20301282	MAXO:0000077	behavioral counseling	HP:0000716	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-07-06
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0000058	pharmacotherapy	HP:0001332	TREATS	TAS	CHEBI:48873	cholinergic antagonist		ORCID:0000-0002-4142-7153	2023-03-04	2022-07-29
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0000058	pharmacotherapy	HP:0001332	TREATS	TAS	CHEBI:22720	benzodiazepine		ORCID:0000-0002-4142-7153	2023-03-04	2022-07-29
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0000058	pharmacotherapy	HP:0001332	TREATS	TAS	CHEBI:15765	L-dopa		ORCID:0000-0002-4142-7153	2023-03-04	2022-07-29
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0009015	botulinum toxin therapy	HP:0001332	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2022-07-29
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0000943	deep brain stimulation	HP:0001332	TREATS	TAS			comment: "stimulation of the globus pallidus interna"	ORCID:0000-0002-4142-7153	2023-03-04	2022-07-29
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0001110	tumorectomy	HP:0006880	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0001110	tumorectomy	HP:0009713	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000453	laser ablation therapy	HP:0009711	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000455	cryosurgery	HP:0009711	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000429	external beam radiation therapy	HP:0009711	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000448	surgical resection	HP:0009711	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0001110	tumorectomy	HP:0005584	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0001065	nephrectomy	HP:0005584	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000455	cryosurgery	HP:0005584	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000447	surgical excision	HP:0002666	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0001110	tumorectomy	HP:0002894	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000447	surgical excision	HP:0001737	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-11	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000058	pharmacotherapy	HP:0002666	TREATS	TAS			comment: "CHEBI:38940"	ORCID:0000-0002-4142-7153	2023-06-14	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000058	pharmacotherapy	HP:0005584	TREATS	TAS			comment: "CHEBI:38940"	ORCID:0000-0002-4142-7153	2023-06-14	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000058	pharmacotherapy	HP:0006880	TREATS	TAS			comment: "CHEBI:177023"	ORCID:0000-0002-4142-7153	2023-06-14	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000058	pharmacotherapy	HP:0009713	TREATS	TAS			comment: "CHEBI:177023"	ORCID:0000-0002-4142-7153	2023-06-14	2022-08-01
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000058	pharmacotherapy	HP:0009713	PREVENTS	TAS			comment: "CHEBI:9513"	ORCID:0000-0002-4142-7153	2023-06-14	2022-08-01
MONDO:0010156	Spastic Paraplegia 20, Autosomal Recessive	PMID:20301556	MAXO:0000275	urinary antispasmodic agent therapy	HP:0000012	TREATS	TAS	CHEBI:27732	caffeine		ORCID:0000-0002-4142-7153	2022-08-16	2022-02-28
MONDO:0011236	Hyperinsulinemic Hypoglycemia, Familial, 3	PMID:9435328	MAXO:0000905	benzodiazepine agent therapy	HP:0000825	TREATS	TAS	CHEBI:4495	diazoxide		ORCID:0000-0002-0736-9199	2022-09-03	2022-09-03
MONDO:0012382	Hyperinsulinemic Hypoglycemia, Familial, 4	PMID:11489939	MAXO:0000905	benzodiazepine agent therapy	HP:0000825	TREATS	TAS	CHEBI:4495	diazoxide		ORCID:0000-0002-0736-9199	2022-09-03	2022-09-03
MONDO:0012382	Hyperinsulinemic Hypoglycemia, Familial, 4	PMID:11489939	MAXO:0000742	thiazide diuretic agent therapy	HP:0000825	TREATS	TAS	CHEBI:3640	chlorothiazide		ORCID:0000-0002-0736-9199	2022-09-03	2022-09-03
MONDO:0009797	Orotic Aciduria	PMID:9042911	MAXO:0010022	uridine supplementation	MONDO:0009797	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-09-06	2022-09-06
MONDO:0013925	Methylmalonic Aciduria And Homocystinuria, Cblj Type	PMID:22922874	MAXO:0010029	methylcobalamin supplementation	MONDO:0013925	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-09-06	2022-09-06
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0000058	pharmacotherapy	HP:0001332	TREATS	TAS	CHEBI:9720	Trihexyphenidyl		ORCID:0000-0002-4142-7153	2023-03-04	2022-09-06
MONDO:0009419	Woodhouse-sakati Syndrome	PMID:27489925	MAXO:0000058	pharmacotherapy	HP:0001332	TREATS	TAS	CHEBI:2972	baclofen		ORCID:0000-0002-4142-7153	2023-03-04	2022-09-06
MONDO:0008783	Tangier Disease	PMID:31751110	MAXO:0010034	corneal transplantation	HP:0007759	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-07	2022-09-06
MONDO:0008547	Thanatophoric Dysplasia, Type Ii	PMID:20301540	MAXO:0000504	tracheostomy	HP:0002093	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-16	2022-09-06
MONDO:0008546	Thanatophoric Dysplasia, Type I	PMID:20301540	MAXO:0000504	tracheostomy	HP:0002093	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-02-07	2022-09-06
MONDO:0013521	Dyskeratosis Congenita, Autosomal Dominant 2	PMID:27192671	MAXO:0000286	androgen modifying agent therapy	MONDO:0013521	TREATS	PCS	CHEBI:4315	danazol	comment: "multiple mechanisms of action"	ORCID:0000-0001-7941-2961	2022-09-12	2022-09-12
MONDO:0013878	Pulmonary Fibrosis And/or Bone Marrow Failure, Telomere-related, 1	PMID:27192671	MAXO:0000286	androgen modifying agent therapy	MONDO:0013878	TREATS	PCS	CHEBI:4315	danazol	comment: "multiple  mechanisms of action"	ORCID:0000-0001-7941-2961	2022-09-12	2022-09-12
MONDO:0014590	Myasthenic Syndrome, Congenital, 18	PMID:25381298	MAXO:0000434	calcium channel blocking agent therapy	HP:0001324	TREATS	TAS	CHEBI:51599	2,4-diaminopyridine		ORCID:0000-0002-0736-9199	2022-09-27	2022-09-27
MONDO:0007765	Hyperostosis Cranialis Interna	PMID:20140965	MAXO:0000004	surgical procedure	HP:0010628	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-10-01	2022-10-01
MONDO:0013460	Osteogenesis Imperfecta, Type Xii	PMID:20579626	MAXO:0000954	bisphosphonate agent therapy	HP:0040160	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0014081	Card11 Immunodeficiency	PMID:23561803	MAXO:0000747	hematopoietic stem cell transplantation	HP:0002721	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0014081	Card11 Immunodeficiency	PMID:23374270	MAXO:0000747	hematopoietic stem cell transplantation	HP:0002721	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0009561	Mannosidosis, Alpha B, Lysosomal	PMID:29716835	MAXO:0000933	enzyme replacement or supplementation therapy	MONDO:0009561	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0009561	Mannosidosis, Alpha B, Lysosomal	PMID:20301570	MAXO:0009030	hearing aid usage	HP:0000407	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0009561	Mannosidosis, Alpha B, Lysosomal	PMID:20301570	MAXO:0000747	hematopoietic stem cell transplantation	MONDO:0009561	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0011399	Alpha-thalassemia	PMID:20301608	MAXO:0000747	hematopoietic stem cell transplantation	MONDO:0011399	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0011399	Alpha-thalassemia	PMID:20301608	MAXO:0000756	blood transfusion	HP:0004840	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0011399	Alpha-thalassemia	PMID:20301608	MAXO:0001225	iron chelator agent therapy	MONDO:0011399	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0008692	Abetalipoproteinemia	PMID:30358967	MAXO:0010024	essential fatty acid supplementation	HP:0002630	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0008692	Abetalipoproteinemia	PMID:30358967	MAXO:0001135	fat soluble vitamin supplementation	HP:0002630	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-06	2022-11-06
MONDO:0013395	Retinitis Pigmentosa 4	PMID:35940643	MAXO:0001001	gene therapy	MONDO:0013395	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-07	2022-11-07
MONDO:0014462	Focal Segmental Glomerulosclerosis 8	PMID:24676636	MAXO:0000601	renal dialysis	HP:0003774	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-07	2022-11-07
MONDO:0013867	Brown-vialetto-van Laere Syndrome 2	PMID:24253200	MAXO:0010016	riboflavin supplementation	HP:0007141	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-07	2022-11-07
MONDO:0000902	Agenesis Of The Corpus Callosum With Peripheral Neuropathy	PMID:20301546	MAXO:0000011	physical therapy	HP:0001371	PREVENTS	TAS				ORCID:0000-0002-0736-9199	2022-11-08	2022-11-08
MONDO:0000902	Agenesis Of The Corpus Callosum With Peripheral Neuropathy	PMID:20301546	MAXO:0000482	orthotic device usage	HP:0003690	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-08	2022-11-08
MONDO:0000902	Agenesis Of The Corpus Callosum With Peripheral Neuropathy	PMID:20301546	MAXO:0000166	antipsychotic agent therapy	HP:0000709	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-08	2022-11-08
MONDO:0011297	Epilepsy, Nocturnal Frontal Lobe, 2	PMID:20301348	MAXO:0000167	anticonvulsant agent therapy	HP:0002133	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0011297	Epilepsy, Nocturnal Frontal Lobe, 2	PMID:20301348	MAXO:0000942	vagus nerve stimulation	HP:0002133	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0011545	Epilepsy, Nocturnal Frontal Lobe, 3	PMID:11104662	MAXO:0000942	vagus nerve stimulation	HP:0001250	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0011545	Epilepsy, Nocturnal Frontal Lobe, 3	PMID:11104662	MAXO:0000167	anticonvulsant agent therapy	HP:0001250	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0010899	Epilepsy, Nocturnal Frontal Lobe, 1	PMID:7895015	MAXO:0000167	anticonvulsant agent therapy	HP:0001250	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0010899	Epilepsy, Nocturnal Frontal Lobe, 1	PMID:7895015	MAXO:0000942	vagus nerve stimulation	HP:0001250	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0014002	Epilepsy, Nocturnal Frontal Lobe, 5	PMID:20301348	MAXO:0000167	anticonvulsant agent therapy	HP:0002133	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0014002	Epilepsy, Nocturnal Frontal Lobe, 5	PMID:20301348	MAXO:0000942	vagus nerve stimulation	HP:0002133	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-07	2022-11-11
MONDO:0009194	Immunodeficiency 32b	PMID:21524210	MAXO:0000747	hematopoietic stem cell transplantation	MONDO:0009194	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-11	2022-11-11
MONDO:0013836	Coenzyme Q10 Deficiency, Primary, 6	PMID:21540551	MAXO:0010012	coenzyme Q10 supplementation	MONDO:0013836	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-26	2022-11-26
MONDO:0012784	Coenzyme Q10 Deficiency, Primary, 4	PMID:32337771	MAXO:0010012	coenzyme Q10 supplementation	MONDO:0012784	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-11-26	2022-11-26
MONDO:0009591	Metachromatic Leukodystrophy	PMID:32792226	MAXO:0000933	enzyme replacement or supplementation therapy	MONDO:0009591	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-12-12	2022-12-12
MONDO:0009591	Metachromatic Leukodystrophy	PMID:19067349	MAXO:0010033	umbilical cord blood transplantation	MONDO:0009591	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-12-12	2022-12-12
MONDO:0012407	Pyridoxamine 5-prime-phosphate Oxidase Deficiency	PMID:24645144	MAXO:0001131	pyridoxine supplementation	HP:0001250	TREATS	TAS				ORCID:0000-0002-0736-9199	2022-12-18	2022-12-18
MONDO:0011724	Glut1 Deficiency Syndrome 1	PMID:12555938	MAXO:0030010	ketogenic diet intake	HP:0001250	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-17	2023-01-17
MONDO:0011724	Glut1 Deficiency Syndrome 1	PMID:15622525	MAXO:0030010	ketogenic diet intake	HP:0001250	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-17	2023-01-17
MONDO:0009820	Osteoporosis-pseudoglioma Syndrome	PMID:21407258	MAXO:0000954	bisphosphonate agent therapy	HP:0000939	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-22	2023-01-22
MONDO:0009820	Osteoporosis-pseudoglioma Syndrome	PMID:35393770	MAXO:0000954	bisphosphonate agent therapy	HP:0000939	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-22	2023-01-22
MONDO:0007903	Li-fraumeni Syndrome	PMID:27501770	MAXO:0000751	clinical surveilance	MONDO:0007903	PREVENTS	TAS				ORCID:0000-0002-0736-9199	2023-01-23	2023-01-23
MONDO:0010926	Hypocalciuric Hypercalcemia, Familial, Type Iii	PMID:24081735	MAXO:0010115	dietary calcium avoidance	HP:0003072	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-26	2023-01-26
MONDO:0010998	Congenital Disorder Of Glycosylation, Type Id	PMID:32389449	MAXO:0030010	ketogenic diet intake	HP:0001250	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-26	2023-01-26
MONDO:0060491	Neurodevelopmental Disorder With Involuntary Movements	PMID:26060304	MAXO:0000943	deep brain stimulation	HP:0004305	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-28	2023-01-28
MONDO:0060491	Neurodevelopmental Disorder With Involuntary Movements	PMID:28357411	MAXO:0000943	deep brain stimulation	HP:0004305	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-28	2023-01-28
MONDO:0018274	Amish Infantile Epilepsy Syndrome	PMID:30691927	MAXO:0000167	anticonvulsant agent therapy	HP:0002069	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-30	2023-01-30
MONDO:0018274	Amish Infantile Epilepsy Syndrome	PMID:15502825	MAXO:0000942	vagus nerve stimulation	HP:0002069	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-30	2023-01-30
MONDO:0014434	Bardet-biedl Syndrome 5	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-01-31	2022-02-15
MONDO:0009174	Enteropathy, Protein-losing	PMID:28657829	MAXO:0001262	micronutrient supplementation	HP:0001510	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-31	2023-01-31
MONDO:0009174	Enteropathy, Protein-losing	PMID:28657829	MAXO:0001129	vitamin supplementation	HP:0001510	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-01-31	2023-01-31
MONDO:0019014	Palmoplantar Keratoderma, Mutilating, With Periorificial Keratoticplaques	PMID:22405088	MAXO:0000237	retinoid agent therapy	HP:0000982	TREATS	TAS	CHEBI:50172	acitretin		ORCID:0000-0002-0736-9199	2023-02-04	2023-02-04
MONDO:0019014	Palmoplantar Keratoderma, Mutilating, With Periorificial Keratoticplaques	PMID:22405088	MAXO:0000237	retinoid agent therapy	HP:0000989	TREATS	TAS	CHEBI:50172	acitretin		ORCID:0000-0002-0736-9199	2023-02-04	2023-02-04
MONDO:0013458	Hyperuricemia, Pulmonary Hypertension, Renal Failure, And Alkalosis	PMID:21255763	MAXO:0000908	phosphodiesterase inhibitor therapy	HP:0002092	TREATS	TAS	CHEBI:9139	sildenafil		ORCID:0000-0002-0736-9199	2023-02-04	2023-02-04
MONDO:0014446	Bardet-biedl Syndrome 18	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-04	2022-02-22
MONDO:0013840	Coenzyme Q10 Deficiency, Primary, 5	PMID:19375058	MAXO:0010012	coenzyme Q10 supplementation	HP:0003128	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-07	2023-02-07
MONDO:0014447	Bardet-biedl Syndrome 19	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-17
MONDO:0014926	Bardet-biedl Syndrome 20	PMID:20301537	MAXO:0000088	dietary intervention	HP:0001513	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-02-07	2022-02-17
MONDO:0009959	Refsum Disease, Infantile Form	PMID:34664020	MAXO:0010119	dietary phytanic acid intake avoidance	MONDO:0009959	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-07	2023-02-07
MONDO:0009959	Refsum Disease, Infantile Form	PMID:34664020	MAXO:0001142	docosahexaenoic acid supplementation	MONDO:0009959	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-07	2023-02-07
MONDO:0009959	Refsum Disease, Infantile Form	PMID:34664020	MAXO:0001255	cholic acid supplementation	MONDO:0009959	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-07	2023-02-07
MONDO:0009959	Refsum Disease, Infantile Form	PMID:15184617	MAXO:0010119	dietary phytanic acid intake avoidance	MONDO:0009959	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-08	2023-02-08
MONDO:0044316	Thrombocytopenia, Anemia, And Myelofibrosis	PMID:27743390	MAXO:0000760	vitamin B12 supplementation	HP:0001903	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0044316	Thrombocytopenia, Anemia, And Myelofibrosis	PMID:27743390	MAXO:0001128	folic acid supplementation	HP:0001903	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0044316	Thrombocytopenia, Anemia, And Myelofibrosis	PMID:27743390	MAXO:0000108	iron supplementation	HP:0001903	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0008668	Von Willebrand Disease, Type 1	PMID:20301765	MAXO:0000446	desmopressin agent therapy	HP:0012147	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0008668	Von Willebrand Disease, Type 1	PMID:29200009	MAXO:0000445	antifibrinolytic agent therapy	HP:0006298	PREVENTS	TAS	CHEBI:48669	tranexamic acid		ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0008668	Von Willebrand Disease, Type 1	PMID:29200009	MAXO:0000445	antifibrinolytic agent therapy	HP:0004846	PREVENTS	TAS	CHEBI:48669	tranexamic acid		ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0013000	Porphyria, Acute Hepatic	PMID:2063868	MAXO:0001175	liver transplantation	MONDO:0013000	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0013607	Immunodeficiency 21	PMID:21816832	MAXO:0000747	hematopoietic stem cell transplantation	HP:0002721	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0007064	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative,b Cell-negative, Nk Cell-negative, Due To Adenosine Deaminase Deficiency	PMID:20301656	MAXO:0010030	bone marrow transplantation	HP:0004430	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0007064	Severe Combined Immunodeficiency, Autosomal Recessive, T Cell-negative,b Cell-negative, Nk Cell-negative, Due To Adenosine Deaminase Deficiency	PMID:20301656	MAXO:0000933	enzyme replacement or supplementation therapy	HP:0004430	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0013607	Immunodeficiency 21	PMID:22996659	MAXO:0000441	granulocyte colony stimulating factor agent therapy	HP:0001875	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0014423	Immunodeficiency 26 With Or Without Neurologic Abnormalities	PMID:19075392	MAXO:0000747	hematopoietic stem cell transplantation	HP:0004430	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0010533	Arts Syndrome	PMID:8498830	MAXO:0009025	cochlear device implantation	HP:0000365	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-02-11	2022-02-22
MONDO:0033014	Erythrokeratodermia Variabilis Et Progressiva 4	PMID:28575652	MAXO:0000237	retinoid agent therapy	HP:0010783	TREATS	TAS	CHEBI:6067	isotretinoin		ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0033014	Erythrokeratodermia Variabilis Et Progressiva 4	PMID:28575652	MAXO:0000237	retinoid agent therapy	HP:0000962	TREATS	TAS	CHEBI:6067	isotretinoin		ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0014168	Immunodeficiency 8	PMID:19097825	MAXO:0000747	hematopoietic stem cell transplantation	HP:0002721	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0007158	Arthrogryposis, Distal, Type 5	PMID:23487782	MAXO:0000011	physical therapy	HP:0005684	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0007688	Myhre Syndrome	PMID:28406602	MAXO:0000930	speech therapy	HP:0001608	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-11	2023-02-11
MONDO:0008030	Facioscapulohumeral Muscular Dystrophy 1	PMID:33712050	MAXO:0000112	food antioxidant supplementation	HP:0003547	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0008030	Facioscapulohumeral Muscular Dystrophy 1	PMID:33712050	MAXO:0000065	aerobic exercise therapy	HP:0003547	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0012589	Pitt-hopkins Syndrome	PMID:22934316	MAXO:0000011	physical therapy	HP:0001270	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0012589	Pitt-hopkins Syndrome	PMID:22934316	MAXO:0000058	pharmacotherapy	HP:0002883	TREATS	TAS	CHEBI:27690	acetazolamide		ORCID:0000-0001-5208-3432	2023-02-12	2022-06-10
OMIM:277480	Von Willebrand Disease, Type 3	PMID:20301765	MAXO:0000446	desmopressin agent therapy	HP:0008330	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
OMIM:277480	Von Willebrand Disease, Type 3	PMID:20301765	MAXO:0000445	antifibrinolytic agent therapy	HP:0001892	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0008044	Myoclonic Dystonia	PMID:21220679	MAXO:0000943	deep brain stimulation	HP:0001336	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0008044	Myoclonic Dystonia	PMID:21825253	MAXO:0000943	deep brain stimulation	HP:0001336	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0014334	Immunodeficiency 22	PMID:9664084	MAXO:0010030	bone marrow transplantation	HP:0002721	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0013456	Megaloblastic Anemia Due To Dihydrofolate Reductase Deficiency	PMID:21310277	MAXO:0001128	folic acid supplementation	HP:0001889	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-12	2023-02-12
MONDO:0013531	Phosphoserine Phosphatase Deficiency	PMID:25080166	MAXO:0010021	serine supplementation	MONDO:0013531	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-13	2023-02-13
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0009089	stereotactic radiosurgery using Gamma Knife	HP:0006880	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-16	2023-02-13
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0009088	stereotactic radiosurgery	HP:0006880	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-16	2023-02-13
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0009088	stereotactic radiosurgery	HP:0009713	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-16	2023-02-13
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0009089	stereotactic radiosurgery using Gamma Knife	HP:0009713	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-16	2023-02-13
MONDO:0010200	Wilson Disease	PMID:20301685	MAXO:0009095	zinc therapy	MONDO:0010200	TREATS	TAS				ORCID:0000-0002-4142-7153	2023-03-04	2023-02-13
MONDO:0012522	Diabetes Mellitus, Transient Neonatal, 3	PMID:15784703	MAXO:0000743	sulfonylurea agent therapy	HP:0008255	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-18	2023-02-18
MONDO:0012522	Diabetes Mellitus, Transient Neonatal, 3	PMID:15784703	MAXO:0000259	therapeutic insulin treatment	HP:0008255	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-18	2023-02-18
MONDO:0011214	Cholestasis, Progressive Familial Intrahepatic, 3	PMID:9419367	MAXO:0001175	liver transplantation	MONDO:0011214	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-21	2023-02-21
MONDO:0013166	Gaba-transaminase Deficiency	PMID:28411234	MAXO:0000905	benzodiazepine agent therapy	MONDO:0013166	TREATS	TAS	CHEBI:5103	flumazenil		ORCID:0000-0002-0736-9199	2023-02-23	2023-02-23
MONDO:0011787	Muscular Dystrophy-dystroglycanopathy (limb-girdle), Type C, 5	PMID:17200494	MAXO:0000065	aerobic exercise therapy	HP:0003701	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-24	2023-02-24
MONDO:0009666	Holocarboxylase Synthetase Deficiency	PMID:8319716	MAXO:0010010	biotin supplementation	MONDO:0009666	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-25	2023-02-25
MONDO:0009666	Holocarboxylase Synthetase Deficiency	PMID:8319716	MAXO:0000603	peritoneal dialysis	MONDO:0009666	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-25	2023-02-25
MONDO:0012041	Familial Adenomatous Polyposis, 2	PMID:35988966	MAXO:0001213	colorectal polypectomy	HP:0005227	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-25	2023-02-25
MONDO:0012041	Familial Adenomatous Polyposis, 2	PMID:35988966	MAXO:0001042	colectomy	HP:0005227	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-02-25	2023-02-25
MONDO:0014584	Myasthenic Syndrome, Congenital, 3b, Fast-channel	PMID:11435464	MAXO:0000210	cholinesteriase inhibitor therapy	HP:0001324	TREATS	TAS	CHEBI:8665	Pyridostigmine		ORCID:0000-0002-0736-9199	2023-02-26	2023-02-26
MONDO:0020723	Vitamin D-dependent Rickets, Type I	PMID:9486994	MAXO:0000110	vitamin D supplementation	HP:0002748	TREATS	TAS	CHEBI:17823	calcitriol		ORCID:0000-0002-0736-9199	2023-02-26	2023-02-26
MONDO:0008104	Noonan Syndrome 1	PMID:11316696	MAXO:0000780	human growth hormone replacement therapy	HP:0004322	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-02	2023-03-02
MONDO:0008104	Noonan Syndrome 1	PMID:15956085	MAXO:0000780	human growth hormone replacement therapy	HP:0004322	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-02	2023-03-02
MONDO:0008104	Noonan Syndrome 1	PMID:11344190	MAXO:0000780	human growth hormone replacement therapy	HP:0004322	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-02	2023-03-02
MONDO:0007947	Marfan Syndrome	PMID:8790089	MAXO:0001220	removal of lens	HP:0001083	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-13	2023-03-13
MONDO:0007947	Marfan Syndrome	PMID:35902413	MAXO:0000653	angiotensin receptor blocker therapy	HP:0002616	TREATS	TAS	CHEBI:6541	losartan		ORCID:0000-0002-0736-9199	2023-03-13	2023-03-13
MONDO:0009352	Homocystinuria Due To Cystathionine Beta-synthase Deficiency	PMID:5658866	MAXO:0001128	folic acid supplementation	HP:0002160	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-14	2023-03-14
MONDO:0010626	Immunodeficiency, X-linked, With Hyper-igm	PMID:14663287	MAXO:0000295	immunological agent therapy	HP:0002721	TREATS	PCS			comment: "intravenous immunglobulin"	ORCID:0000-0001-9969-9517	2023-04-09	2023-03-14
MONDO:0010626	Immunodeficiency, X-linked, With Hyper-igm	PMID:1757090	MAXO:0000640	corticosteroid agent therapy	HP:0001875	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-04-09	2023-03-14
MONDO:0008967	Bile Acid Synthesis Defect, Congenital, 4	PMID:12512044	MAXO:0001255	cholic acid supplementation	MONDO:0008967	TREATS	TAS			comment: "Reannotate to Decreased serum bile acid concentra"	ORCID:0000-0002-0736-9199	2023-03-15	2023-03-15
MONDO:0032735	Cataract 48	PMID:30290152	MAXO:0009043	cataract extraction with intraocular lens insertion	MONDO:0032735	TREATS	TAS			comment: "reannotate with HPO Cataract"	ORCID:0000-0002-0736-9199	2023-03-15	2023-03-15
MONDO:0010626	Immunodeficiency, X-linked, With Hyper-igm	PMID:7542361	MAXO:0010030	bone marrow transplantation	HP:0002721	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-04-09	2023-03-15
MONDO:0033558	Autoinflammation, Immune Dysregulation, And Eosinophilia	PMID:28111307	MAXO:0009096	Janus kinase inhibitor therapy	HP:0001880	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-04-09	2023-03-15
MONDO:0010421	Agammaglobulinemia, X-linked	PMID:26909497	MAXO:0000061	antibacterial agent therapy	HP:0002090	PREVENTS	TAS			comment: "cotrimoxazole prophylaxis"	ORCID:0000-0001-9969-9517	2023-03-16	2023-03-15
MONDO:0007644	Immunoglobulin A Deficiency 1	PMID:9544978	MAXO:0010030	bone marrow transplantation	HP:0002720	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-03-16	2023-03-16
MONDO:0009974	Hemophagocytic Lymphohistiocytosis, Familial, 1	PMID:9389690	MAXO:0010030	bone marrow transplantation	HP:0012156	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-03-16	2023-03-16
MONDO:0009061	Cystic Fibrosis	PMID:17018651	MAXO:0000780	human growth hormone replacement therapy	HP:0001510	PREVENTS	PCS				ORCID:0000-0001-9969-9517	2023-03-16	2023-03-16
MONDO:0011285	Macular Degeneration, Age-related, 1	PMID:14769599	MAXO:0000169	anti-inflammatory agent therapy	HP:0000529	TREATS	PCS	CHEBI:9667	triamcinolone	comment: "triamcinoloneacetonide"	ORCID:0000-0003-4830-7530	2023-03-16	2023-03-15
MONDO:0009861	Phenylketonuria	PMID:20091517	MAXO:0010094	dietary phenylalanine intake avoidance	HP:0004923	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-03-21	2023-03-16
MONDO:0010444	Anemia, X-linked, With Or Without Neutropenia And/or Platelet Abnormalities	PMID:16783379	MAXO:0010030	bone marrow transplantation	HP:0001875	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-21	2023-03-21
MONDO:0010444	Anemia, X-linked, With Or Without Neutropenia And/or Platelet Abnormalities	PMID:20301538	MAXO:0000756	blood transfusion	HP:0001972	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-21	2023-03-21
MONDO:0014306	Vasculitis, Autoinflammation, Immunodeficiency, And Hematologic Defects Syndrome	PMID:25075845	MAXO:0000747	hematopoietic stem cell transplantation	HP:0001876	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-23	2023-03-23
MONDO:0013653	Parkinson Disease 18	PMID:21907011	MAXO:0000157	antiparkinson agent therapy	HP:0001300	TREATS	TAS	CHEBI:15765	L-dopa		ORCID:0000-0002-0736-9199	2023-03-27	2023-03-27
MONDO:0010520	Alport Syndrome, X-linked	PMID:9195222	MAXO:0010043	kidney transplantation	HP:0003774	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-29	2023-03-29
MONDO:0010518	Wiskott-aldrich Syndrome	PMID:3995178	MAXO:0001077	splenectomy	HP:0001873	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-06-14	2023-03-29
MONDO:0010518	Wiskott-aldrich Syndrome	PMID:21067383	MAXO:0000747	hematopoietic stem cell transplantation	HP:0000964	TREATS	PCS			comment: "genetically modified hematopoietic stem cells"	ORCID:0000-0001-9969-9517	2023-06-14	2023-03-29
MONDO:0010916	Polycystic Kidney Disease 3	PMID:25292408	MAXO:0000603	peritoneal dialysis	HP:0000083	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-04-16	2023-03-29
MONDO:0009669	Spinal Muscular Atrophy, Type I	PMID:31371124	MAXO:0001001	gene therapy	HP:0007269	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-04-16	2023-03-29
MONDO:0013619	Nephrotic Syndrome, Type 6	PMID:21722858	MAXO:0010043	kidney transplantation	HP:0003774	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-03-31	2023-03-31
MONDO:0013619	Nephrotic Syndrome, Type 6	PMID:21722858	MAXO:0000640	corticosteroid agent therapy	HP:0000100	TREATS	TAS	CHEBI:6889	methylprednisolone acetate		ORCID:0000-0002-0736-9199	2023-03-31	2023-03-31
MONDO:0013619	Nephrotic Syndrome, Type 6	PMID:21722858	MAXO:0000297	immune suppressant agent therapy	HP:0000100	TREATS	TAS	CHEBI:4031	cyclosporin A		ORCID:0000-0002-0736-9199	2023-03-31	2023-03-31
MONDO:0011518	Wiedemann-steiner Syndrome	PMID:35617449	MAXO:0000090	enteral nutrition intake	HP:0001508	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-14	2023-04-05
MONDO:0011518	Wiedemann-steiner Syndrome	PMID:35617449	MAXO:0000780	human growth hormone replacement therapy	HP:0001510	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-05
MONDO:0011518	Wiedemann-steiner Syndrome	PMID:35617449	MAXO:0000110	vitamin D supplementation	HP:0002750	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-05
MONDO:0012269	Chromosome 3q29 Deletion Syndrome	PMID:27656750	MAXO:0000883	cognitive behavior therapy	HP:0001249	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-04-16	2023-04-05
MONDO:0012269	Chromosome 3q29 Deletion Syndrome	PMID:27656750	MAXO:0000732	occupational therapist evaluation	HP:0000733	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-04-16	2023-04-05
MONDO:0012269	Chromosome 3q29 Deletion Syndrome	PMID:27656750	MAXO:0000090	enteral nutrition intake	HP:0001508	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-04-16	2023-04-05
MONDO:0012342	Williams-beuren Region Duplication Syndrome	PMID:26610320	MAXO:0000930	speech therapy	HP:0001263	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-05
MONDO:0012774	Chromosome 15q13.3 Microdeletion Syndrome	PMID:21290787	MAXO:0001117	seizure prevention recommendation	HP:0001250	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-10	2023-04-05
MONDO:0012774	Chromosome 15q13.3 Microdeletion Syndrome	PMID:21290787	MAXO:0000883	cognitive behavior therapy	HP:0000708	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-10	2023-04-05
MONDO:0011426	Aceruloplasminemia	PMID:20301666	MAXO:0001225	iron chelator agent therapy	HP:0003281	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-04-16	2023-04-05
MONDO:0013869	Adenine Phosphoribosyltransferase Deficiency	PMID:22934314	MAXO:0009072	surgical repair	HP:0000787	TREATS	TAS			comment: "Remove kidney stones"	ORCID:0000-0003-4830-7530	2023-06-10	2023-04-06
MONDO:0009958	Refsum Disease	PMID:20301527	MAXO:0010119	dietary phytanic acid intake avoidance	HP:0001251	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-06
MONDO:0009958	Refsum Disease	PMID:20301527	MAXO:0010119	dietary phytanic acid intake avoidance	HP:0007141	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-06
MONDO:0009958	Refsum Disease	PMID:20301527	MAXO:0000097	fasting avoidance	HP:0010571	PREVENTS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-06
MONDO:0011382	Sickle Cell Anemia	PMID:36992422	MAXO:0001001	gene therapy	MONDO:0011382	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-07	2023-04-07
MONDO:0011382	Sickle Cell Anemia	PMID:25203083	MAXO:0000233	antimetabolite agent therapy	HP:0008346	TREATS	TAS	CHEBI:44423	hydroxyurea		ORCID:0000-0003-4830-7530	2023-04-07	2023-04-05
MONDO:0029132	Liddle Syndrome 3	PMID:28710092	MAXO:0000741	potassium-sparing diuretic agent therapy	HP:0000822	TREATS	PCS	CHEBI:9671	triamterene		ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0009216	Fanconi-bickel Syndrome	PMID:3153325	MAXO:0000110	vitamin D supplementation	HP:0004915	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0009216	Fanconi-bickel Syndrome	PMID:3153325	MAXO:0010097	dietary galactose intake avoidance	HP:0004915	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0009216	Fanconi-bickel Syndrome	PMID:7564233	MAXO:0030018	uncooked cornstarch supplementation	HP:0004915	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0008765	Leber Congenital Amaurosis, Type Ii	PMID:36672611	MAXO:0001001	gene therapy	HP:0007663	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0009216	Fanconi-bickel Syndrome	PMID:11044475	MAXO:0030018	uncooked cornstarch supplementation	HP:0004915	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0009216	Fanconi-bickel Syndrome	PMID:11044475	MAXO:0010097	dietary galactose intake avoidance	HP:0004915	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-08	2023-04-08
MONDO:0010292	Uruguay Faciocardiomusculoskeletal Syndrome	PMID:26933038	MAXO:0000187	beta-adrenergic antagonist therapy	HP:0001714	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-09	2023-04-09
MONDO:0007637	Corneal Dystrophy, Fuchs Endothelial, 1	PMID:36637659	MAXO:0000024	surgical procedure on the eye	MONDO:0007637	TREATS	PCS				ORCID:0000-0002-6601-4486	2023-06-16	2023-04-10
MONDO:0009633	Microspherophakia	PMID:20617341	MAXO:0001220	removal of lens	HP:0030961	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-10	2023-04-10
MONDO:0007453	Maturity-onset Diabetes Of The Young, Type Ii	PMID:1570017	MAXO:0000743	sulfonylurea agent therapy	HP:0004904	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-10	2023-04-10
MONDO:0024537	Brown-vialetto-van Laere Syndrome 1	PMID:20206331	MAXO:0010016	riboflavin supplementation	MONDO:0024537	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-11	2023-04-11
MONDO:0009215	Fanconi Anemia	PMID:20301575	MAXO:0009030	hearing aid usage	HP:0000365	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-12
MONDO:0009215	Fanconi Anemia	PMID:20301575	MAXO:0000291	androgen stimulant agent therapy	HP:0001873	TREATS	TAS			comment: "Oral"	ORCID:0000-0003-4830-7530	2023-06-15	2023-04-12
MONDO:0009215	Fanconi Anemia	PMID:20301575	MAXO:0000747	hematopoietic stem cell transplantation	HP:0001876	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-12
MONDO:0009215	Fanconi Anemia	PMID:20301575	MAXO:0000441	granulocyte colony stimulating factor agent therapy	HP:0001875	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-12
MONDO:0011831	Arrhythmogenic Right Ventricular Dysplasia, Familial, 8	PMID:31078652	MAXO:0000185	antiarrythmic agent therapy	MONDO:0011831	PREVENTS	PCS				morgan.similuk@nih.gov	2023-06-16	2023-04-12
MONDO:0011831	Arrhythmogenic Right Ventricular Dysplasia, Familial, 8	PMID:31078652	MAXO:0000802	avoid excessive exercise	HP:0001645	PREVENTS	TAS				morgan.similuk@nih.gov	2023-04-16	2023-04-12
MONDO:0019569	Cockayne Syndrome A	PMID:30252254	MAXO:0001220	removal of lens	HP:0000518	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-14
MONDO:0019569	Cockayne Syndrome A	PMID:30252254	MAXO:0000055	sunlight avoidance	HP:0003224	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-14
MONDO:0019570	Cockayne Syndrome, Type B	PMID:30252254	MAXO:0001220	removal of lens	HP:0000518	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-14
MONDO:0009613	Methylmalonic Aciduria, Cbla Type	PMID:32754920	MAXO:0000760	vitamin B12 supplementation	MONDO:0009613	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-15	2023-04-15
MONDO:0009613	Methylmalonic Aciduria, Cbla Type	PMID:32754920	MAXO:0010006	carnitine supplementation	MONDO:0009613	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-15	2023-04-15
MONDO:0007281	Cataract, Crystalline Aculeiform	PMID:9718335	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0000519	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-16	2023-04-16
MONDO:0007285	Cataract 1, Multiple Types	PMID:14627691	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0100018	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-16	2023-04-16
MONDO:0009549	Stargardt Disease 1	PMID:27491360	MAXO:0001001	gene therapy	MONDO:0009549	TREATS	TAS				ORCID:0000-0002-6601-4486	2023-04-16	2023-04-16
MONDO:0008294	Porphyria, Acute Intermittent	PMID:20301372	MAXO:0000092	excessive alcohol avoidance	MONDO:0008294	PREVENTS	TAS				ORCID:0000-0003-4830-7530	2023-04-16	2023-04-06
MONDO:0011426	Aceruloplasminemia	PMID:20301666	MAXO:0010100	dietary iron intake avoidance	MONDO:0011426	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-04-16	2023-04-05
MONDO:0013700	Pancreatic Lipase Deficiency	PMID:24262094	MAXO:0001135	fat-soluble vitamin supplementation	MONDO:0013700	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-18	2023-04-18
MONDO:0011303	Focal Segmental Glomerulosclerosis 1	PMID:26740551	MAXO:0000603	peritoneal dialysis	HP:0003774	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-18	2023-04-18
MONDO:0011303	Focal Segmental Glomerulosclerosis 1	PMID:26740551	MAXO:0010043	whole kidney transplantation	HP:0003774	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-18	2023-04-18
MONDO:0014887	Bone Marrow Failure Syndrome 3	PMID:28062395	MAXO:0001135	fat-soluble vitamin supplementation	MONDO:0014887	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-18	2023-04-18
MONDO:0014896	Muscular Dystrophy, Congenital, Davignon-chauveau Type	PMID:27008887	MAXO:0000503	artificial respiration	HP:0002747	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-18	2023-04-18
MONDO:0008876	Bloom Syndrome	PMID:20301572	MAXO:0000259	therapeutic insulin treatment	HP:0005978	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-19
MONDO:0016368	Rothmund-thomson Syndrome, Type 1	PMID:20301415	MAXO:0000453	laser ablation therapy	HP:0001029	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-10	2023-04-19
MONDO:0016368	Rothmund-thomson Syndrome, Type 1	PMID:20301415	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0001118	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-10	2023-04-19
MONDO:0016369	Rothmund-thomson Syndrome	PMID:20301415	MAXO:0000453	laser ablation therapy	HP:0001009	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-19
MONDO:0016369	Rothmund-thomson Syndrome	PMID:20301415	MAXO:0009043	cataract extraction with intraocular lens insertion	HP:0000518	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-19
MONDO:0008310	Hutchinson-gilford Progeria Syndrome	PMID:20301300	MAXO:0000178	anticoagulant agent therapy	HP:0001658	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-19
MONDO:0013921	Herpes Simplex Encephalitis, Susceptibility To, 4	PMID:22105173	MAXO:0000168	antiviral agent therapy	HP:0012302	TREATS	TAS	CHEBI:59495	cidofovir dihydrate		ORCID:0000-0002-0736-9199	2023-04-22	2023-04-22
MONDO:0012014	Charcot-marie-tooth Disease, Recessive Intermediate A	PMID:12499475	MAXO:0000482	orthotic device usage	HP:0007340	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-04-22	2023-04-22
MONDO:0014911	Growth Retardation, Impaired Intellectual Development, Hypotonia, And Hepatopathy	PMID:27426735	MAXO:0010026	zinc supplementation	HP:0031831	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-07	2023-05-07
MONDO:0014647	Epileptic Encephalopathy, Early Infantile, 50	PMID:28007989	MAXO:0010022	uridine supplementation	HP:0001250	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-08	2023-05-08
MONDO:0007494	Episodic Kinesigenic Dyskinesia 1	PMID:23535490	MAXO:0000208	sodium channel inhibitor therapy	HP:0002268	TREATS	TAS	CHEBI:3387	carbamazepine		ORCID:0000-0002-0736-9199	2023-05-08	2023-05-08
MONDO:0007100	Amyloidosis Vii	PMID:8097803	MAXO:0001175	liver transplantation	HP:0011034	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-09	2023-05-09
MONDO:0008310	Hutchinson-gilford Progeria Syndrome	PMID:34281245	MAXO:0001469	farnesyltransferase inhibitor agent therapy	MONDO:0008310	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-05-17
MONDO:0009109	Lysinuric Protein Intolerance	PMID:3917550	MAXO:0010018	citrulline supplementation	HP:0004322	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-20	2023-05-20
MONDO:0009109	Lysinuric Protein Intolerance	PMID:18716612	MAXO:0010018	citrulline supplementation	HP:0004322	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-20	2023-05-20
MONDO:0013945	Peroxisome Biogenesis Disorder 9b	PMID:17325280	MAXO:0010119	dietary phytanic acid intake avoidance	HP:0010571	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-20	2023-05-20
MONDO:0013945	Peroxisome Biogenesis Disorder 9b	PMID:17325280	MAXO:0010032	cardiac transplantation	HP:0001638	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-05-20	2023-05-20
MONDO:0013499	Fanconi Anemia, Complementation Group P	PMID:21240277	MAXO:0000747	hematopoietic stem cell transplantation	HP:0001876	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-04	2023-04-12
MONDO:0012518	Myasthenia, Limb-girdle, With Tubular Aggregates	PMID:30635494	MAXO:0000645	acetylcholinesterase inhibitor therapy	HP:0003473	TREATS	TAS	CHEBI:8665	Pyridostigmine		ORCID:0000-0002-0736-9199	2023-06-10	2023-06-10
MONDO:0010421	Agammaglobulinemia, X-linked	PMID:26909497	MAXO:0001480	immunoglobulin infusion therapy	HP:0004432	TREATS	PCS				ORCID:0000-0001-9969-9517	2023-06-10	2023-03-15
MONDO:0008564	Digeorge Syndrome	PMID:28400115	MAXO:0010042	thymic transplantation	HP:0000777	TREATS	PCS			comment: "thymus transplantation"	ORCID:0000-0001-9969-9517	2023-06-10	2023-03-29
MONDO:0009437	Hypothyroidism, Athyroidal, With Spiky Hair And Cleft Palate	PMID:9697705	MAXO:0001474	thyroid hormone therapy	HP:0000851	TREATS	TAS	CHEBI:30660	thyroxine		ORCID:0000-0002-0736-9199	2023-06-10	2023-06-10
MONDO:0008221	Prolidase Deficiency	PMID:26110198	MAXO:0000756	blood transfusion	HP:0001903	TREATS	TAS				ORCID:0000-0001-5208-3432	2023-06-14	2022-06-11
MONDO:0008221	Prolidase Deficiency	PMID:26110198	MAXO:0010020	amino acid supplementation	MONDO:0008221	TREATS	TAS	CHEBI:26271	proline		ORCID:0000-0001-5208-3432	2023-06-14	2022-06-11
MONDO:0008667	Von Hippel-lindau Syndrome	PMID:20301636	MAXO:0000058	pharmacotherapy	HP:0009711	TREATS	TAS			comment: "ranibizumab"	ORCID:0000-0002-4142-7153	2023-06-14	2022-08-01
MONDO:0007037	Achondroplasia	PMID:20301331	MAXO:0000479	orthopedic surgery	HP:0005733	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-06
MONDO:0007037	Achondroplasia	PMID:20301331	MAXO:0000479	orthopedic surgery	HP:0008414	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-06
MONDO:0009958	Refsum Disease	PMID:20301527	MAXO:0010119	dietary phytanic acid intake avoidance	HP:0010571	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-15	2023-04-06
MONDO:0009958	Refsum Disease	PMID:20301527	MAXO:0010119	dietary phytanic acid intake avoidance	HP:0008064	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-06-15	2023-06-15
MONDO:0012180	Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	PMID:26320108	MAXO:0000474	implantable cardioverter-defibrillator placement	HP:0004308	PREVENTS	PCS				morgan.similuk@nih.gov	2023-06-15	2023-04-12
MONDO:0012180	Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	PMID:29084731	MAXO:0000185	antiarrythmic agent therapy	HP:0004308	PREVENTS	PCS			comment: "PMID: 29084731"	morgan.similuk@nih.gov	2023-06-15	2023-04-12
MONDO:0012180	Arrhythmogenic Right Ventricular Dysplasia, Familial, 9	PMID:31078652	MAXO:0000802	avoid excessive exercise	HP:0004308	PREVENTS	PCS				morgan.similuk@nih.gov	2023-06-15	2023-04-12
MONDO:0012342	Williams-beuren Region Duplication Syndrome	PMID:26610320	MAXO:0001117	seizure prevention recommendation	HP:0001250	PREVENTS	TAS				ORCID:0000-0003-4830-7530	2023-06-16	2023-04-05
MONDO:0008876	Bloom Syndrome	PMID:20301572	MAXO:0000054	radiation exposure avoidance	MONDO:0008876	PREVENTS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-19
MONDO:0008876	Bloom Syndrome	PMID:20301572	MAXO:0000055	sunlight avoidance	MONDO:0008876	PREVENTS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-18
MONDO:0008840	Ataxia-telangiectasia	PMID:20301790	MAXO:0001480	immunoglobulin infusion therapy	HP:0004315	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-19
MONDO:0007665	Glaucoma, Primary Open Angle	PMID:15474813	MAXO:0000960	viscocanalostomy	HP:0012108	TREATS	PCS				ORCID:0000-0002-6601-4486	2023-06-22	2023-04-30
MONDO:0007665	Glaucoma, Primary Open Angle	PMID:30488337	MAXO:0000959	canaloplasty	HP:0012108	TREATS	PCS				ORCID:0000-0002-6601-4486	2023-06-22	2023-04-30
MONDO:0007665	Glaucoma, Primary Open Angle	PMID:28237137	MAXO:0001082	trabeculectomy	HP:0012108	TREATS	PCS				ORCID:0000-0002-6601-4486	2023-06-22	2023-04-30
MONDO:0010896	Glaucoma-related Pigment Dispersion Syndrome	PMID:33444629	MAXO:0000187	beta-adrenergic antagonist therapy	HP:0012108	TREATS	TAS				ORCID:0000-0002-6601-4486	2023-06-22	2023-04-30
MONDO:0010896	Glaucoma-related Pigment Dispersion Syndrome	PMID:33444629	MAXO:0000309	ophthalmic prostaglandin and prostamide agent therapy	HP:0012108	TREATS	PCS				ORCID:0000-0002-6601-4486	2023-06-22	2023-04-30
MONDO:0019570	Cockayne Syndrome, Type B	PMID:30252254	MAXO:0000090	enteral nutrition intake	HP:0001525	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-14
MONDO:0019569	Cockayne Syndrome A	PMID:30252254	MAXO:0000090	enteral nutrition intake	HP:0008850	TREATS	TAS				ORCID:0000-0003-4830-7530	2023-06-22	2023-04-14
MONDO:0012043	Corneal Dystrophy, Reis-bucklers Type	PMID:36977302	MAXO:0010034	corneal transplantation	HP:0001131	TREATS	PCS				ORCID:0000-0002-6601-4486	2023-06-22	2023-04-17
MONDO:0009662	Mucopolysaccharidosis Type Vii	PMID:29478819	MAXO:0000933	enzyme replacement or supplementation therapy	HP:0003541	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-07-08	2023-07-08
MONDO:0009662	Mucopolysaccharidosis Type Vii	PMID:9543069	MAXO:0001479	allogeneic hematopoietic stem cell transplantation	HP:0003541	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-07-08	2023-07-08
MONDO:0021056	Adenomatous Polyposis Coli	PMID:20301519	MAXO:0000014	radiation therapy	HP:0100245	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-07-08	2022-01-25
MONDO:0021056	Adenomatous Polyposis Coli	PMID:20301519	MAXO:0000646	cancer chemotherapy	HP:0100245	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-07-08	2022-01-25
MONDO:0021056	Adenomatous Polyposis Coli	PMID:20301519	MAXO:0000635	anti-estrogen agent therapy	HP:0100245	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-07-08	2022-01-25
MONDO:0021056	Adenomatous Polyposis Coli	PMID:20301519	MAXO:0000221	nonsteroidal anti-inflammatory agent therapy	HP:0100245	TREATS	TAS				ORCID:0000-0001-7941-2961	2023-07-08	2022-01-25
MONDO:0011971	Immunodeficiency With Hyper-igm, Type 5	PMID:12958596	MAXO:0001480	immunoglobulin infusion therapy	HP:0004315	TREATS	TAS				ORCID:0000-0002-0736-9199	2023-07-11	2023-07-11
MONDO:0100079	Epileptic Encephalopathy, Early Infantile, 6 (dravet Syndrome)	PMID:9596203	MAXO:0000208	sodium channel inhibitor therapy	HP:0032794	CONTRAINDICATED	TAS	CHEBI:6367	lamotrigine	comment: "Seizures can worsen on withdrawing lamotrigine."	ORCID:0000-0002-1735-8178	2023-07-12	2023-07-12
